InsiderClue
← All stocks

Attovia Therapeutics, Inc.

ATTO Net buying
CIK 0002058707 #5987 in the set updated 17 Sep 2026
Bought (120 mo)
$52.37M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$4.50M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$4.50M
46 of 46 sales
Net
+$47.87M
+$47.87M against sales at will

By person

7 insiders · 55 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Redmile Group, LLC entity
10% owner
$10.20M (2)
—
+$10.20M
2,165,708
$36.82M
+176.6%
Frazier Life Sciences XI, L.P.
10% owner
$10.00M (1)
—
+$10.00M
6,154,213
$104.62M
+8,068%
GOLDMAN SACHS GROUP INC entity
Former 10% Owner
$10.29M (2)
$2.25M (23)
+$8.03M
3,020,632
$51.35M
+2,755%
WALSH COLIN
Director
$10.29M (2)
$2.25M (23)
+$8.03M
3,020,632
$51.35M
+2,755%
venBio Global Strategic Fund IV, L.P. entity
10% owner
$6.50M (1)
—
+$6.50M
4,181,367
$71.08M
—
Sanofi
10% owner
$5.10M (1)
—
+$5.10M
1,082,855
$18.41M
—
Deep Track Biotechnology Master Fund, Ltd. entity
10% owner
—
—
—
1,957,138
$33.27M
—

No percentages here. Attovia Therapeutics, Inc. reports its share count only per share class, which the XBRL frames API does not carry.

Individual transactions

9
Insider
Date
Role
Action
Shares
Price
Amount
Frazier Life Sciences XI, L.P.
6 Aug 2026
10% owner
Buy
588,235
$17.00
$10.00M
Sanofi
6 Aug 2026
10% owner
Buy indirect
300,000
$17.00
$5.10M
Redmile Group, LLC
6 Aug 2026
10% owner
Buy indirect
400,000
$17.00
$6.80M
Redmile Group, LLC
6 Aug 2026
10% owner
Buy
200,000
$17.00
$3.40M
venBio Global Strategic Fund IV, L.P.
6 Aug 2026
10% owner
Buy
382,352
$17.00
$6.50M
GOLDMAN SACHS GROUP INC
6 Aug 2026
Former 10% Owner
Buy indirect
500,000
$17.00
$8.50M
WALSH COLIN
6 Aug 2026
Director
Buy indirect
500,000
$17.00
$8.50M
GOLDMAN SACHS GROUP INC
5 Aug 2026
Former 10% Owner
Buy indirect
85,000
$21.00
$1.79M
WALSH COLIN
5 Aug 2026
Director
Buy indirect
85,000
$21.00
$1.79M
Show all 55 transactions →

What was left out

Form 4 filings counted 14
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 46
Transactions with no price 0
Shares from compensation/vesting 17,683,755
History held since 6 Aug 2026